Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
19.92
-1.06 (-5.05%)
At close: Dec 5, 2025, 4:00 PM EST
19.88
-0.04 (-0.20%)
After-hours: Dec 5, 2025, 5:55 PM EST
Tectonic Therapeutic Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2014 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '14 Dec 31, 2014 |
| Revenue | - | - | - | - | - | 0.14 | |
| Revenue Growth (YoY) | - | - | - | - | - | 2.13% | |
| Gross Profit | - | - | - | - | - | 0.14 | |
| Selling, General & Admin | 20.21 | 16.65 | 7.68 | 7.18 | 4.63 | - | |
| Research & Development | 56.3 | 41.36 | 36.97 | 25.65 | 10.98 | - | |
| Operating Expenses | 76.51 | 58.02 | 44.65 | 32.83 | 15.61 | - | |
| Operating Income | -76.51 | -58.02 | -44.65 | -32.83 | -15.61 | - | |
| Interest Expense | -0.07 | -0.11 | -0.15 | -0.14 | -0.45 | - | |
| Interest & Investment Income | 10.47 | 4.26 | 0.58 | 0.15 | - | - | |
| Other Non Operating Income (Expenses) | -0.21 | -4.12 | 1.4 | 0.65 | 8.1 | - | |
| EBT Excluding Unusual Items | -66.32 | -57.98 | -42.82 | -32.18 | -7.96 | - | |
| Other Unusual Items | - | - | - | - | -0.97 | - | |
| Pretax Income | -66.32 | -57.98 | -42.82 | -32.18 | -8.93 | - | |
| Earnings From Continuing Operations | - | -57.98 | -42.82 | -32.18 | -8.93 | - | |
| Net Income | -67.3 | -57.98 | -42.82 | -32.18 | -8.93 | 0.01 | |
| Net Income to Common | -67.3 | -57.98 | -42.82 | -32.18 | -8.93 | - | |
| Shares Outstanding (Basic) | 17 | 8 | 1 | 3 | - | - | |
| Shares Outstanding (Diluted) | 17 | 8 | 1 | 3 | - | - | |
| Shares Change (YoY) | 239.27% | 569.30% | -49.78% | - | - | - | |
| EPS (Basic) | -3.88 | -6.83 | -33.76 | -12.74 | - | - | |
| EPS (Diluted) | -3.88 | -6.83 | -33.76 | -12.74 | - | - | |
| Free Cash Flow | -62.65 | -59.24 | -40.96 | -29.73 | -14.58 | - | |
| Free Cash Flow Per Share | -3.61 | -6.98 | -32.29 | -11.77 | - | - | |
| Gross Margin | - | - | - | - | - | 100.00% | |
| EBITDA | -74.96 | -56.37 | -43.17 | -31.82 | -15.25 | - | |
| D&A For EBITDA | 1.55 | 1.65 | 1.48 | 1.01 | 0.36 | - | |
| EBIT | -76.51 | -58.02 | -44.65 | -32.83 | -15.61 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.